Back to search

Article

The lack of trade-off between conformational stability and binding affinity in a nanobody with therapeutic potential for a misfolding disease

2024-09-19

Abstract excerpt

To improve protein pharmaceuticals, we need to balance protein stability and binding affinity with in vivo efficiency. We have recently developed a nanobody (NB-AGT-2) against the alanine:glyoxylate aminotransferase with high stability ( T m ∼85°C) that may be useful to treat a misfolding disease called primary hyperoxaluria type 1. In this work, we characterize the relationships between protein stability and bi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c5bb5b9-e707-59f8-b1ce-136e18c527da
DOI
10.1101/2024.09.15.612864
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The lack of trade-off between conformational stability and binding affinity in a nanobody with therapeutic potential for a misfolding diseaseDOI 10.1101/2024.09.15.612864
Select a neighboring publication to make it the new centre.